Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• X-linked adrenoleukodystrophy (ALD) can progress to a fatal cerebral form (cALD).
• The underlying mechanisms driving this phenotypic switch are not fully understood.
• Identifying predictive biomarkers is crucial for timely intervention.

Purpose of the Study:

• To investigate differences in antioxidant capacity and superoxide dismutase (SOD) activity between ALD phenotypes (cALD, adrenomyeloneuropathy [AMN]), female carriers, and healthy controls.
• To assess the potential of these markers as predictors for cALD development.

Main Methods:

• Collected blood plasma and monocyte samples from healthy controls, female carriers, and male patients with AMN or cALD.
• Assayed total antioxidant capacity and SOD activity using commercially available kits.
• Correlated antioxidant levels with clinical data, including MRI severity scores.

Main Results:

• Significantly reduced antioxidant capacity and SOD activity were observed across ALD phenotypes compared to controls.
• Plasma SOD activity showed a strong inverse correlation with cALD brain MRI severity.
• Longitudinal data indicated decreasing SOD activity preceding cerebral diagnosis.

Conclusions:

• Plasma SOD levels are significantly diminished in patients with ALD, particularly in the cerebral form.
• Plasma SOD activity may serve as a valuable predictive biomarker for cerebral ALD.
• Early identification of cALD risk through SOD monitoring could facilitate prompt, life-saving therapies.